Vice President, Strategy & New Business Development

RESPONSIBILITIES:

Strategy and Execution

• Lead the development and ongoing refinement of PI's long-range strategy, integrating market dynamics, customer needs, competitive activity, technology trends, clinical evidence, and

enterprise priorities.

• Partner with the Worldwide President and PI Leadership Team to translate strategy into clear portfolio choices, investment priorities, strategic initiatives, and measurable outcomes.
• Lead the annual strategic review process and ensure alignment across platforms, regions, R&D, Clinical, Medical Affairs, Finance, Regulatory, Quality, Integrated Supply Chain, and Commercial teams.
• Provide objective, fact-based perspectives on portfolio tradeoffs, resource allocation, risk, and value-creation potential.

New Business Development and Inorganic Growth

• Define strategic theses and priority hunting grounds aligned to PI's growth priorities across vascular and cancer care.
• Proactively source acquisition, investment, licensing, technology, and partnership opportunities through relationships with company executives, entrepreneurs, clinicians, inventors, universities,

venture and private-equity investors, investment bankers, advisers, and participants across the global MedTech ecosystem.

• Develop an external network of innovators, entrepreneurs, physicians, investors, bankers, industry partners, and other ecosystem participants to improve opportunity access and market insight.
• Lead initial screening and strategic fit assessment of opportunities, determining where PI should engage, monitor, partner, invest, or decline.

Opportunity Assessment, Diligence and Deal Support

• Lead integrated assessment of market attractiveness, customer need, competitive differentiation, technology maturity, clinical and regulatory pathway, intellectual property, commercial potential, financial returns, operational requirements, and risk.
• Develop decision-ready business cases, including market models, valuation scenarios, revenue and margin potential, investment requirements, key assumptions, sensitivities, and value-creation

plans.

• Present recommendations to PI, Segment, and enterprise senior leadership with clear strategic rationale and transparent risk assessment.
• Partner with Corporate Development and functional leaders through diligence, negotiation, approval, transaction execution, and transition planning.

Portfolio Governance, Integration and Value Realization

• Establish a rigorous PI Strategy and New Business Development operating model, including decision rights, governance, stage gates, evaluation criteria, portfolio reviews, funnel management, and executive reporting.
• Increase organizational clock speed by clarifying ownership, improving cross-functional coordination, and driving timely decisions while maintaining appropriate quality and risk discipline.
• Connect inorganic opportunities to organic pipeline strategy, platform roadmaps, clinical evidence plans, market access priorities, and commercialization requirements.
• Ensure integration considerations and value-creation requirements are incorporated early in opportunity assessment and decision-making.
• Provide continuity from strategic thesis through deal rationale, integration planning, and realization of intended strategic and financial outcomes.

Supervisory/Management Responsibilities

• Build, lead, and develop a high-performing Strategy and New Business Development team with deep market expertise, strong external networks, and disciplined analytical capability.
• Create a culture of enterprise thinking, constructive challenge, accountability, speed, collaboration, inclusion, and high ethical standards.
• Influence effectively without relying solely on formal authority and build alignment across diverse senior stakeholders.

Fiscal Responsibilities

• Own and manage the annual PI Strategy and New Business Development operating budget.
• Guide portfolio investment choices and resource allocation through disciplined strategic and financial analysis.
• Develop and challenge valuation models, financial returns, investment requirements, sensitivities, and value-creation assumptions.
• Ensure transaction-related spending, external-adviser support, and diligence investments are appropriately prioritized and governed.

EXPERIENCE & EDUCATION:

• Bachelor's degree in business, engineering, life sciences, finance, or a related field required; MBA or other relevant advanced degree strongly preferred.
• 12+ years of progressive strategy, business development, corporate development, portfolio management, or related experience, including significant leadership experience in medical devices or closely related healthcare technology.
• Deep understanding of medical-device markets, transaction dynamics, and product development requirements. Experience in peripheral vascular, venous, interventional oncology, biopsy, or

adjacent procedural markets strongly preferred.

• Demonstrated experience developing and executing growth strategies and building actionable pipelines of inorganic opportunities.
• Proven experience leading complex opportunity assessments and cross-functional due diligence; direct experience supporting acquisitions, investments, licensing, partnerships, negotiations, and

integration is strongly preferred.

• Demonstrated ability to build market models, evaluate strategic and financial attractiveness, andtranslate complex analysis into clear executive recommendations.
• Experience working across global markets and with senior enterprise leadership, boards, investment committees, or comparable governance bodies.
• Experience leading and developing high-performing teams and influencing across a complex matrixed organization.
• Experience in peripheral vascular, interventional oncology, medical devices, or adjacent clinical and technology markets is strongly preferred.

KNOWLEDGE, SKILLS AND ABILITIES:

• Strategic and portfolio acumen across markets, platforms, technologies, and time horizons.
• Strong external orientation and ability to build trusted relationships across the innovation and investment ecosystem.
• Commercial and financial judgment that integrates customer, clinical, technology, financial, and execution considerations.
• Executive presence and enterprise influence; ability to constructively challenge assumptions and communicate complex matters clearly.
• Execution discipline, sound judgment, learning agility, and resilience in ambiguous, high-stakes environments.
• Demonstrated commitment to talent development, inclusion, collaboration, accountability, ethics, and integrity.
• Ability to handle highly confidential information, work across time zones, and travel globally as business needs require.